Melatonin enhances NK cell function in aged mice by increasing T-bet expression via the JAK3-STAT5 signaling pathway.
Level 5 - mechanism / opinion, no new human data
Animal and mechanistic bench study (Oxford CEBM Level 5).
PubMed 39237911 · doi:10.1186/s12979-024-00459-8
What was done
Researchers investigated the molecular mechanisms by which melatonin alters natural killer (NK) cell senescence and function in aging mice. They evaluated NK cell counts, proliferation, degranulation, interferon-gamma (IFN-γ) secretion, maturation, activation status, and downstream signaling pathways involving JAK3, STAT5, and the transcription factor T-bet.
What was found
The abstract reports qualitative findings without specific numerical values or statistical metrics: melatonin administration significantly increased the number and functional activity of NK cells in aged mice, enhancing proliferation, degranulation, and IFN-γ production. Mechanistic evaluation showed that melatonin promoted NK cell maturation and activation through the JAK3/STAT5 pathway, leading to increased T-bet expression.
Why it matters
This study identifies a specific pathway (JAK3/STAT5/T-bet) through which melatonin may counteract age-related NK cell dysfunction, offering potential targets for reversing immunosenescence.
Limits
The study was conducted strictly in mice and cellular models, so direct applicability to human immune aging remains unproven. The abstract lacks details on sample size, treatment dosing, exposure duration, and quantitative effect sizes.
Cited by
- supports Melatonin regulates angiogenesis and natural killer cell activity.